Revolutionizing the Treatment of Neurological DiseasesBrainsway Ltd. occupies a unique niche in the field of medical technology with its flagship product - the Deep Transcranial Magnetic Stimulation (Deep TMS) system. This cutting-edge technology offers an innovative approach to treating a wide range of neurological and psychiatric disorders, including major depressive disorder and obsessive-compulsive disorder, providing an important alternative to traditional drug treatment.
The Deep TMS technology is distinguished by its high efficacy and safety, confirmed by clinical trials and FDA approval. This opens up access for the company to the growing market of medical devices for treating mental disorders, where the need for innovative solutions remains high.
Brainsway continues to expand its clinical program, exploring new applications for Deep TMS technology in various medical fields. Investments in scientific research and the development of new applications can open additional markets and increase the company's growth potential.
The company demonstrates strong financial performance, supported by increased sales of its Deep TMS systems and the growing number of procedures using its technology. Strategic partnerships and geographic expansion also contribute to revenue growth and strengthen Brainsway's positions in the international market.
In conclusion, Brainsway offers investors a unique opportunity to invest in a company at the forefront of medical innovations, with technology that has the potential to radically change approaches to treating neurological and psychiatric diseases. Considering its potential for growth and expansion, BWAY shares may be of interest to investors seeking diversification in the healthcare and biotechnology sector.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
BWAY trade ideas
$BWAY - (Beyond Technical Analysis - Click in to read) About:
BrainsWay is dedicated to developing and providing advanced solutions for brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. BrainsWay’s flagship technology, which is based on Deep Transcranial Magnetic Stimulation (TMS), launches a new era in brain disorder treatment.
BrainsWay’s treatment is based on patents filed by the U.S. National Institutes of Health (NIH), and by the company. The company holds an exclusive license from the NIH for the patent and for its unique technology.
BrainsWay’s treatment is FDA-cleared for treating depressive episodes in adult patients suffering from Major Depressive Disorder, who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode (FDA 510(k) No. K122288). BrainsWay is also approved in Canada for the treatment of Major Depressive Disorder (Health Canada Licence No. 90504).
BrainsWay runs clinical research programs with leading scientists worldwide, collaborating with prominent institutions and researchers in clinical trials covering various neuropsychiatric and neuroscience applications.
The company’s technology has already helped thousands of people worldwide in both private clinics and clinical studies. It has also been enthusiastically embraced by leading research institutions worldwide, with over 60 clinical trials held around the globe.
Why Now?
Post-Traumatic Stress Disorder: Finally, once the worst of the corona pandemic will be behind us and the world will start to regain a sense of stability, symptoms of PTSD will likely begin to appear. The remnants of a traumatic or deeply destabilizing occurrence has been shown to linger well beyond the actual event, and continue generations into the future.
At present, there are a number of proven treatments for anxiety-based conditions, such as social anxiety or OCD; depressive disorders such as MDD; and PTSD. Such treatments, which include psychotherapy, medication and non-invasive treatment options, have been shown to target adverse symptoms and help bring about a sense of relief.
Technically :
Only Above 8.32!
Not holding yet.
Not for a suggestion!